Description: More than a CRO, a creative R&D team. Innovative R&D companies developing in-house R&D projects and offering preclinical and clinical R&D services.
Pharmahungary Group is a group of R&D companies developing novel in-house R&D projects for valorization (co-development/out-licensing) as well as providing innovative preclinical (nonclinical) and clinical R&D services with strong scientific and regulatory support.
Innovative and cost-effective preclinical (nonclinical) CRO services from cells to large animal models focusing on cardiovascular (infarct size, heart failure, sepsis, stroke etc.), metabolic (diabetes, hyperlipidemia, atherosclerosis, obesity etc.), renal, inflammation, and neuropathy diseases.
Innovative preclinical R&D services from cells to large animal models including e.g. porcine and Göttingen minipig models of several cardiovascular diseases.